Results 81 to 90 of about 643,979 (187)

A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. [PDF]

, 2020
Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%.
Amin, Alpesh N, Chang, Yongen, Cheng, Timmy T, Choi, Grace, Ferrey, Antoney J, Gohil, Shruti, Hanna, Ramy M, Hsieh, Lanny, Huang, Susan S, Ivaturi, Kaushik, Kalantar-Zadeh, Kamyar, Lau, Wei Ling, Lee, Richard A, Nguyen, Lawrence, Park, Elisa, Reddy, Uttam, Rhee, Connie M, Tantisattamo, Ekamol, Tonthat, Sam, Wang, Brian   +19 more
core   +1 more source

Proposed measures to be taken by ophthalmologists during the coronavirus disease 2019 pandemic: Experience from Chang Gung Memorial Hospital, Linkou, Taiwan

Taiwan Journal of Ophthalmology, 2020
PURPOSE: Although Taiwan was one of the first countries to develop coronavirus disease 2019 (COVID-19), with effective antiepidemic measures, Taiwan has effectively controlled the spread of the disease.
Jui-Yen Lin, Eugene Yu-Chuan Kang, Po-Han Yeh, Xiao Chun Ling, Hung-Chi Chen, Kuan-Jen Chen, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu   +8 more
doaj   +1 more source

Effect of Smoking on the Progression and Severity of COVID-19 Infection among Adult Males in Sullia Taluk of Dakshina Kannada

Journal of Indian Association of Public Health Dentistry
Context Coronavirus disease 2019 (COVID-19) primarily targets pulmonary epithelial cells, causing viral pneumonia and acute respiratory distress syndrome. It progresses more severely in chronic obstructive pulmonary disease patients.
Christa Jose, Nusrath Fareed, P. K. Asmin, Hemanth Battur, Jaseela Praveena   +4 more
doaj   +1 more source

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Critical Care Explorations, 2020
Objectives:. Coronavirus disease 2019 patients admitted to the ICU have high mortality. The host response to coronavirus disease 2019 has only been partially elucidated, and prognostic biomarkers have not been identified. We performed targeted proteomics
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Eric K. Patterson, PhD, Marat Slessarev, MD, MSc, Claudio Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Guillaume Pare, MD, MSc, Ioannis Prassas, PhD, Eleftherios Diamandis, MD, PhD, on behalf of the Lawson COVID19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn   +27 more
doaj   +1 more source

Human monkeypox preparedness in Latin America – Are we ready for the next viral zoonotic disease outbreak after COVID-19?

Brazilian Journal of Infectious Diseases, 2022
Sergio Cimerman, Alberto Chebabo, Clovis Arns da Cunha, Alexandre Naime Barbosa, Alfonso J. Rodríguez-Morales   +4 more
doaj   +1 more source

The great lockdown: was it worth it? CEPS Policy Insights No 2020-11 / May 2020 [PDF]

, 2020
What the IMF calls the ‘great lockdown’ has thrown Europe and the global economy into a deep recession. When putting their countries into lockdown, governments essentially pushed the panic button, mostly in the face of rising fatalities.
Gros, Daniel
core  

Prevención e identificación temprana de casos sospechosos COVID-19 en el primer nivel de atención en Centro América

Atención Primaria, 2021
Karla Iveth Henriquez-Marquez, Lysien I. Zambrano, Kovy Arteaga-Livias, Alfonso J. Rodríguez-Morales   +3 more
doaj   +1 more source

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?

Critical Care Explorations, 2020
Objectives:. Aspergillus coinfection in coronavirus disease 2019 patients has rarely been described but may be occurring among coronavirus disease 2019 patients admitted to ICUs.
Karlyn D. Beer, MS, PhD, Brendan R. Jackson, MD, MPH, Tom Chiller, MD, MTMH, Paul E. Verweij, MD, PhD, Frank L. Van de Veerdonk, MD, PhD, Joost Wauters, MD, PhD   +5 more
doaj   +1 more source

Love thy neighbour? Coronavirus politics and their impact on EU freedoms and rule of law in the Schengen Area. CEPS Paper in Liberty and Security in Europe No. 2020-04, April 2020 [PDF]

, 2020
Restrictions on international and intra-EU traffic of persons have been at the heart of the political responses to the coronavirus pandemic. Border controls and suspensions of entry and exist have been presented as key policy priorities to prevent the ...
Carrera, Sergio, Luk, Ngo Chun
core  

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients

Critical Care Explorations, 2020
Objectives:. Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 infection to which there is no community immunity. Patients admitted to ICUs have high mortality, with only supportive therapies available.
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Marat Slessarev, MD, MSc, Claudio Martin, MD, MSc, Mark Daley, PhD, Michael R. Miller, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Eric K. Patterson, PhD, Claudia C. dos Santos, MD, MSc, on behalf of the Lawson COVID-19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn   +24 more
doaj   +1 more source